OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel Drugs with High Efficacy against Tumor Angiogenesis
Shiyu Qi, Shoulong Deng, Zhengxing Lian, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 6934-6934
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

VEGF signaling: Role in angiogenesis and beyond
Pallab Shaw, Shailendra Kumar Dhar Dwivedi, Resham Bhattacharya, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189079-189079
Closed Access | Times Cited: 57

Vascular smooth muscle cells in intimal hyperplasia, an update
Sébastien Déglise, Clémence Bechelli, Florent Allagnat
Frontiers in Physiology (2023) Vol. 13
Open Access | Times Cited: 53

Recent advances of anti-angiogenic inhibitors targeting VEGF/VEGFR axis
Lei Wang, Wang‐Qing Liu, Sylvain Broussy, et al.
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 37

A Molecular Perspective on HIF-1α and Angiogenic Stimulator Networks and Their Role in Solid Tumors: An Update
Anuja Gajanan Magar, Vivek Kumar Morya, Mi Kyung Kwak, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3313-3313
Open Access | Times Cited: 21

Vascular Endothelial Growth Factor-D (VEGF-D): An Angiogenesis Bypass in Malignant Tumors
Syeda Mahak Zahra Bokhari, Péter Hamar
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13317-13317
Open Access | Times Cited: 29

Inhibiting Angiogenesis by Anti-Cancer Saponins: From Phytochemistry to Cellular Signaling Pathways
Mohammad Bagher Majnooni, Sajad Fakhri, Mustafa Ghanadian, et al.
Metabolites (2023) Vol. 13, Iss. 3, pp. 323-323
Open Access | Times Cited: 24

Association of VEGF promoter polymorphisms with gastrointestinal tract cancer risk and therapy response: a systematic review
Deepanshi Mahajan, Vasudha Sambyal, Kamlesh Guleria
Egyptian Journal of Medical Human Genetics (2025) Vol. 26, Iss. 1
Open Access | Times Cited: 1

Tumor dormancy and relapse: understanding the molecular mechanisms of cancer recurrence
Muhammad Tufail, Canhua Jiang, Ning Li
Military Medical Research (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1

Extracellular vesicles in tumor angiogenesis and resistance to anti‐angiogenic therapy
Zi‐Wu Ye, Zi‐Li Yu, Gang Chen, et al.
Cancer Science (2023) Vol. 114, Iss. 7, pp. 2739-2749
Open Access | Times Cited: 19

HMGB1/RAGE axis in tumor development: unraveling its significance
Anqi Fan, Mengxiang Gao, Xuhuan Tang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 8

Decoding Tumor Angiogenesis for Therapeutic Advancements: Mechanistic Insights
Geetika Kaur, Bipradas Roy
Biomedicines (2024) Vol. 12, Iss. 4, pp. 827-827
Open Access | Times Cited: 7

Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management
Vasiliki Katsi, Ilias Papakonstantinou, Konstantinos Tsioufis
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11786-11786
Open Access | Times Cited: 16

Targeting tumor-associated macrophage: an adjuvant strategy for lung cancer therapy
Lei Liu, Genwang Chen, Sisi Gong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13

Case report: Bevacizumab-induced cerebrovascular events: a case series report and literature review
Ke Chen, Bo Jiang, Huiping Yan, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

The Role of PTP1B in Cardiometabolic Disorders and Endothelial Dysfunction
Mona Sawali, Muhammad Zahid, Shahenda Salah Abdelsalam, et al.
Journal of drug targeting (2025), pp. 1-39
Closed Access

Endothelial cell in tumor angiogenesis: Origins, mechanisms, and therapeutic implication
Yulong Han, B Q Zhu, Shu Meng
Genes & Diseases (2025), pp. 101611-101611
Open Access

Comparison between conventional, grinding, and microwave synthesis of methylpyrazoles as VEGFR-2/HSP90 dual inhibitors
Ebtehal M. Husseiny, Rana M. Abdelnaby, Najla Altwaijry, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access

The Role of HSP90 Inhibitors in the Treatment of Cardiovascular Diseases
Shiyu Qi, Guangyi Ma, Kun Yu, et al.
Cells (2022) Vol. 11, Iss. 21, pp. 3444-3444
Open Access | Times Cited: 16

Emerging applications of anti-angiogenic nanomaterials in oncotherapy
Bicai Tang, Wenjuan Ma, Yunfeng Lin
Journal of Controlled Release (2023) Vol. 364, pp. 61-78
Closed Access | Times Cited: 10

ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma
Tushuai Li, Longjiang Xu, Zhe Wei, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 10

The Role of Extracellular Heat Shock Proteins in Cardiovascular Diseases
Soumya Patnaik, Sriram Nathan, Biswajit Kar, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1557-1557
Open Access | Times Cited: 9

Tumour microenvironment in pheochromocytoma and paraganglioma
Serena Martinelli, Francesca Amore, Letizia Canu, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 8

Page 1 - Next Page

Scroll to top